# TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis

Study · id `cardio:ct-nct06597188` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06597188](<https://clinicaltrials.gov/study/NCT06597188>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06597188

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 452 participants.

## Technical summary

Registry record NCT06597188. Randomized; single masking; primary purpose treatment. Start 2025-09-08 (actual); primary completion 2028-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 452 participants (planned count; ClinicalTrials.gov record NCT06597188, source copy `cardio:ctgov-nct06597188-2025-09-16`, retrieved 2026-10-26)
- Started: 2025-09-08 (actual) (ClinicalTrials.gov record NCT06597188, source copy `cardio:ctgov-nct06597188-2025-09-16`, retrieved 2026-10-26)
- Primary completion: 2028-09-30 (anticipated) (ClinicalTrials.gov record NCT06597188, source copy `cardio:ctgov-nct06597188-2025-09-16`, retrieved 2026-10-26)
- Completion: 2032-09-30 (anticipated) (ClinicalTrials.gov record NCT06597188, source copy `cardio:ctgov-nct06597188-2025-09-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06597188, source copy `cardio:ctgov-nct06597188-2025-09-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06597188-2025-09-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis
- Acronym: PROMIS-BAV
- Condition: Aortic Stenosis
- Condition: Bicuspid Aortic Valve (BAV)
- Intervention (Device): VitaFlow Liberty
- Intervention (Device): Commercially available surgical bioprosthetic valve
- Lead sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: West China Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Anhui Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Zhejiang University
- Collaborator class: OTHER
- Collaborator: Qilu Hospital of Shandong University
- Collaborator class: OTHER
- Collaborator: People's Hospital of Xinjiang Uygur Autonomous Region
- Collaborator class: OTHER
- Collaborator: Fuzhou University Affiliated Provincial Hospital
- Collaborator class: OTHER
- Collaborator: Yan'an Affiliated Hospital of Kunming Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Bicuspid aortic valve (`cardio:bicuspid-aortic-valve`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd. (`cardio:org-shanghai-microport-cardioflow-medtech-co-ltd`)
- Registry lists this organization as a collaborator: West China Hospital (`cardio:org-west-china-hospital`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital of Anhui Medical University (`cardio:org-the-first-affiliated-hospital-of-anhui-medical-university`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Zhejiang University (`cardio:org-first-affiliated-hospital-of-zhejiang-university`)
- Registry lists this organization as a collaborator: Qilu Hospital of Shandong University (`cardio:org-qilu-hospital-of-shandong-university`)
- Registry lists this organization as a collaborator: People's Hospital of Xinjiang Uygur Autonomous Region (`cardio:org-people-s-hospital-of-xinjiang-uygur-autonomous-region`)
- Registry lists this organization as a collaborator: Yan'an Affiliated Hospital of Kunming Medical University (`cardio:org-yan-an-affiliated-hospital-of-kunming-medical-university`)

## Provenance

Content hash: 921f32df3b7bcefbe6918fe46f599541fe0d409b675c9c918564c6d9a604bc77
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
